Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Mach7 Technologies.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Starpharma jumps 10pc on study results; Mach7 announces $3.7m deal
News
Market Highlights: Earnings weigh on Wall Street; VIX falls below 14, signals ‘new bull market’
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall in first week of FY23 as Mach 7 scores biggest deal in its history
Health & Biotech
Which ASX health companies are making strides in world’s largest healthcare market?
Health & Biotech
Check Up: Diet Coke put on notice as WHO labels artificial sweetener aspartame ‘possibly carcinogenic’
Health & Biotech
ScoPo’s (actually Wilkie’s) Powerplays: Inoviq soars on clinical data for breast cancer test
Health & Biotech
4D Medical’s technology disrupts century-old procedures AND makes over 90pc profit margin
Health & Biotech
ScoPo’s Powerplays: ASX health stocks rise, Immutep surges 46pc on trial results
Health & Biotech
Mach 7 positions for enterprise imaging uptake solving tomorrow’s problems with today’s software
Health & Biotech
Why growth is a positive for the ASX medical imaging sector
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall but keep watchful eye on upcoming catalysts
News
Market Highlights: Dilbert comic dropped, ASX to rise, and 5 small caps to watch on Tuesday
Health & Biotech
ScoPo’s Powerplays: ASX health stocks have lacklustre week as Monash IVF continues to gain market share
Health & Biotech
ScoPo’s Powerplays: ASX health stocks rise, Mach 7 lands largest contract and posts record quarter
Health & Biotech
ScoPo’s Powerplays: ASX health stocks sprout 4.6%, as Volpara soars on first positive cash flow
Health & Biotech
Check Up: Japan’s startup OUI wants to halve the world’s blindness with its smartphone device
Health & Biotech
